SCHEMBL4834111

SCHEMBL4834111

O=C1C2C(C(=O)N1OS(=O)(=O)c1cccc3ccccc13)C1C(=O)N(OS(=O)(=O)c3cccc4ccccc34)C(=O)C21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ HTR6 P50406 2/20 0.43
▸ TSHR P16473 1/20 0.41
▸ F2 P00734 3/20 0.40
▸ PRSS1 P07477 3/20 0.40
▸ PRSS2 P07478 3/20 0.40
▸ PRSS3 P35030 3/20 0.40
▸ HTT P42858 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ CNR1 P21554 3/20 0.39
▸ CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL547490 0.88 MEN1 (0.42) CA1CA2CA9MEN1KMT2A
SCHEMBL29964496 0.88 MEN1 (0.42) CA1CA2CA9MEN1KMT2A
SCHEMBL4837508 0.87 MEN1 (0.46) CA1CA2CA9MEN1KMT2A
SCHEMBL5367849 0.83 CA1 (0.47) CA1CA2CA9MEN1KMT2A
SCHEMBL65216 0.81 PARL (0.58) CA1CA2CA9MEN1KMT2A
SCHEMBL2900929 0.81 KDM4E (0.57) CA1CA2CA9MEN1KMT2A
SCHEMBL2895865 0.78 KDM4E (0.46) CA1CA2CA9MEN1KMT2A
SCHEMBL548395 0.78 KDM4E (0.68) CA1CA2CA9MEN1KMT2A
SCHEMBL4834045 0.77 MAPK1 (0.51) CA1CA2CA9MEN1KMT2A
SCHEMBL548394 0.76 ALDH1A1 (0.47) CA1CA2CA9MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 — — US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 — — US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 CA1 603/4885CA2 1249/4885CA9 801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback